Antibodies and Variants Thereof Against PD-L1
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- NANJING LEGEND BIOTECH CO., LTD., Nanjing, China has been assigned a patent (No. US 12168688 B2, initially filed Dec. 28, 2018) developed by five inventors Shuai Yang, Jiangsu, China; Chuan-Chu Chou, Westfield, New Jersey; Shu Wu, Jiangsu, China; Liusong Yin, Jiangsu, China; and Feng Lin, Jiangsu, China, for "Antibodies and variants thereof against PD-L1." . . .